Skip to main content
. Author manuscript; available in PMC: 2008 Nov 12.
Published in final edited form as: Psychiatr Serv. 2008 Oct;59(10):1131–1138. doi: 10.1176/appi.ps.59.10.1131

Table 3.

Predictors of 12 Month Antidepressant Use in a Nationally Representative Sample of Blacks and Whites without Psychiatric Disorders in the past 12 months (n = 7,688). Estimates Based on a Multivariate Logistic Regression Model.

OR 95% CI
Predisposing Factors
  Race
    White 1.00
    Black 0.29 0.21–0.41
  Gender
    Male 1.00
    Female 2.63 2.07–3.33
  Age Groups (Years)
    Young Adult (18–34) 1.00
    Adult (35–64) 1.61 1.26–2.06
    Older Adult (65+) 0.82 0.49–1.36
Need Factors
  Medical Conditions
    No Medical Conditions 1.00
    One or More 1.66 1.27–2.18
  Lifetime Disorders*
    No Disorders
    Major Depression,
    Dysthymia, or Anxiety
    Disorders 2.98 2.40–3.68
Enabling Factors
  Household Income Groups
    $0 – $17,999 1.58 0.85–2.93
    $18,000 – $31,999 1.11 0.68–1.83
    $32,000 – $54,999 1.00
    $55,000+ 1.08 0.78–1.50
  Education Groups (Years)
    < 12 0.94 0.62–1.41
    12 1.00
    13 – 15 0.98 0.69–1.39
    16+ 0.78 0.53–1.16
  Health Insurance Status
    Yes 1.28 0.57–2.87
    No 1.00
*

Based on World Mental Health Composite International Diagnostic Interview

Includes Agoraphobia with and without panic, Generalized Anxiety, Panic, Post-traumatic stress and Social phobia

p < 0.001